Aplastic Anemia
Patients show good response to combination therapy in NIH study
Published in Blood Weekly, April 24th, 2003
More than half (60%) of 122 patients with severe aplastic anemia enrolled in a long-term clinical trial treated with a combination of immunosuppressive agents - equine antithymocyte globulin (ATGAM) lymphocyte immune globulin antithymocyte globulin [equine] sterile solution and cyclosporine - demonstrated significantly increased blood cell counts as early as 3 months into treatment, according to a study conducted within the U.S. National Institutes of Health (NIH).
For patients who responded at 3 months, 86% were alive after 5 years. Overall survival of patients 7 years following combination therapy was 55%, according to the study, published in the Journal of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-04-24)
More Articles from Blood Weekly
- Stem Cell Research
Bone marrow side population cells may aid liver regeneration - Stem Cell Research
Early-acting antiapoptotic cytokines prevent radiation damage - Amyotrophic Lateral Sclerosis
Stem cells contribute to tissue regeneration in mice - Leukemia Therapy
ST1571 pretreatment improves donor lymphocyte infusion efficacy - Umbilical Cord Blood
Sampling site affects blood acidity test results - Alcohol Consumption
An ethanol binge can promotes T cell apoptosis of up to 20% - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
